Abstract ISI
ANNALS OF THE RHEUMATIC DISEASES  (2007)

Basal anti-cyclic citrullinated peptide (anti-ccp) antibodies levels and a decrease in anti-CCP titres are associated with clinical response to adalimumab therapy in rheumatoid arthritis patients

Cuchacovich M.; Catalán, D; Wainstein E.; Gatica H.; Soto, L; Aravena, O; Pesce B,; Sabugo, F; Aguillon, J.